Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Demonstrators protesting the delay in securing the Orkambi drug for cf sufferers.

'Life changing' cystic fibrosis drug Orkambi will be available from next month

Simon Harris made the announcement today in the Dáil.

HEALTH MINISTER SIMON Harris has confirmed that the cystic fibrosis drugs Orkambi and Kalydeco will be available to patients from next month.

Responding to a questions in the Dáil this evening, Minister Harris confirmed that a deal had been reached in principle on the drug.

“These drugs will be available to Irish patients in this country from next month,” Harris said.

The HSE has been involved with negotiations with company Vertex – which manufactures the drugs – over securing their use for Irish people living with cf.

“The message going out to Irish patients from Vertex and the HSE is that these medicines will be available from next month,” said Harris.

The Minister said that an agreement had been reached on principle between the two sides.

“I also wish to inform the Dáil that both parties are working to finalise the contractual arrangements to complete the approval process in advance of the first of May,” he said.

Harris said that he recognised that this had been “an extraordinarily difficult time for cystic fibrosis patients, for their families and for their friends as they have been waiting for this process to conclude”.

People living with cystic fibrosis, their loved ones and advocates have been campaigning for months to try to get the drug approved.

With about 50 new cases of cystic fibrosis diagnosed in Ireland every year, campaigners are extremely eager for Orkambi – which has been heralded by them as a life-saving, ‘miracle’ drug – to be made available.

Cystic fibrosis greatly impacts the lifespan of those with the debilitating condition.

The huge cost of Orkambi – put at €158,000 per year per patient, at a cost to the State of €390 million over the course of five years – led to protracted negotiations.

Talks got underway between the HSE and pharmaceutical company Vertex over the drug last week.

Harris said that further work in the coming days by the HSE would “bring the matter to finality” and that the drug would be available from next month.

Now, the drug along with the drug Kalydeco has been approved and should be available from next month, Minister Harris confirmed.

Read: ‘After the transplant, I looked in the mirror and my eyes weren’t yellow anymore, they were white’

Read: Deal on ‘miracle’ cystic fibrosis drug expected in a matter of weeks

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
35 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.
    JournalTv
    News in 60 seconds